News Releases
Metacrine to Present at Jefferies 2019 Global Healthcare Conference
SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases, today announced that Ken Song, M.D., President and CEO, will present at the
May 21, 2019
Displaying 31 - 40 of 52